Global Antibiotics Market Size & Outlook, 2025-2033
Global antibiotics market, 2021-2033 (US$M)
Related Markets
Global antibiotics market highlights
- The global antibiotics market generated a revenue of USD 53,069.4 million in 2024 and is expected to reach USD 74,069.8 million by 2033.
- The market is expected to grow at a CAGR (2025 - 2033) of 3.7% by 2033.
- In terms of segment, cell wall synthesis inhibitors accounted for a revenue of USD 28,501.3 million in 2024.
- RNA Synthesis Inhibitors is the most lucrative action mechanism segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, Mexico is expected to register the highest CAGR from 2025 to 2033.
Global data book summary
| Market revenue in 2024 | USD 53,069.4 million |
| Market revenue in 2033 | USD 74,069.8 million |
| Growth rate | 3.7% (CAGR from 2025 to 2033) |
| Largest segment | Cell wall synthesis inhibitors |
| Fastest growing segment | RNA Synthesis Inhibitors |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, Mycolic Acid Inhibitors |
Other key industry trends
- In terms of revenue, the North America accounted for 39.4% of the global antibiotics market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, Mexico is the fastest growing regional market and is projected to reach USD 1,448.4 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antibiotics Market Scope
Antibiotics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Nabriva Therapeutics | View profile | 101-250 | Vienna, Wien, Austria, Europe | http://www.nabriva.com |
| Kyorin Pharmaceutical | View profile | 1001-5000 | Tokyo, Tokyo, Japan, Asia | https://www.kyorin-pharm.co.jp |
| Shionogi & Co Ltd | View profile | 6204 | 1-8, Doshomachi 3-chome, Chuo-ku, Osaka, Japan, 541-0045 | http://www.shionogi.co.jp |
| Melinta Therapeutics | View profile | 101-250 | New Haven, Connecticut, United States, North America | http://melinta.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Lupin | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | https://www.lupin.com |
| GSK PLC | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global antibiotics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to antibiotics market will help companies and investors design strategic landscapes.
Cell wall synthesis inhibitors was the largest segment with a revenue share of 53.71% in 2024. Horizon Databook has segmented the Global antibiotics market based on cell wall synthesis inhibitors, protein synthesis inhibitors, dna synthesis inhibitors, rna synthesis inhibitors, mycolic acid inhibitors covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2021-2033)
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- Others
- RNA Synthesis Inhibitors
- DNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Global Antibiotics Type Outlook (Revenue, USD Million, 2021-2033)
- Branded Antibiotics
- Generic Antibiotics
- Global Antibiotics Drug Class Outlook (Revenue, USD Million, 2021-2033)
- Macrolides
- Sulfonamides
- Fluoroquinolones
- 7-ACA
- Others
- Penicillins
- Carbapenems
- Aminoglycosides
- Cephalosporins
Reasons to subscribe to Global antibiotics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global antibiotics market databook
-
Our clientele includes a mix of antibiotics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global antibiotics market , including forecasts for subscribers. This global databook contains high-level insights into Global antibiotics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global antibiotics market size, by regions, 2021-2033 (US$M)
Top 10 countries: Antibiotics market size, 2024 (US$M)
Global antibiotics market share, by drug class, 2024 & 2033 (%, US$M)
Antibiotics market: Opportunity assessment by country
Global antibiotics market, by region, 2024 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
